FDA Drug Application (022260) for VELETRI by ACTELION PHARMS LTD

Back to FDA Applications sponsored by ACTELION PHARMS LTD

Application Number022260
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 1.5MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVELETRI
Active IngredientEPOPROSTENOL SODIUM

Active IngredientCount
List of drugs with Active Ingredient EPOPROSTENOL SODIUM3


Back to FDA Applications sponsored by ACTELION PHARMS LTD